Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)-Reference-Cited by-同舟云学术

Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)

Published:2017-07-06 Issue:10 Volume:49 Page:737-747
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Calza Leonardo¹,Magistrelli Eleonora¹,Colangeli Vincenzo¹,Borderi Marco¹,Bussini Linda¹,Bon Isabella²,Re Maria Carla²,Viale Pierluigi¹

Affiliation:

1. Department of Medical and Surgical Sciences, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy;

2. Clinic of Infectious Diseases and Microbiology Unit, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2017.1339325

Reference40 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Mortality in the Highly Active Antiretroviral Therapy Era

3. Excess Mortality in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy: Temporal Changes and Risk Factors

4. Inflammation, immune activation, and cardiovascular disease in HIV

5. Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Switching Between Antiretroviral Agents Versus Introducing Lipid-lowering Agents for HAART-induced Dyslipidemia;Clinical Therapeutics;2024-06

2. The Effect of Rosuvastatin on Plasma/Serum Levels of High-Sensitivity C-Reactive Protein, Interleukin-6, and D-Dimer in People Living with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis;AIDS Research and Human Retroviruses;2021-11-01

3. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16

4. Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease;Infectious Diseases;2019-06-20

5. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings;Current Opinion in HIV and AIDS;2018-05